Literature DB >> 11237381

Telomerase activity in plasma cell dyscrasias.

D Xu1, C Zheng, S Bergenbrant, G Holm, M Björkholm, Q Yi, A Gruber.   

Abstract

Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237381      PMCID: PMC2363791          DOI: 10.1054/bjoc.2000.1655

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  An integrated nanoliter DNA analysis device.

Authors:  M A Burns; B N Johnson; S N Brahmasandra; K Handique; J R Webster; M Krishnan; T S Sammarco; P M Man; D Jones; D Heldsinger; C H Mastrangelo; D T Burke
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

2.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter.

Authors:  Y S Cong; J Wen; S Bacchetti
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

Review 3.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

4.  Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells.

Authors:  Q Yi; S Dabadghao; A Osterborg; S Bergenbrant; G Holm
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

5.  Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.

Authors:  P Sallinen; H Miettinen; S L Sallinen; H Haapasalo; H Helin; J Kononen
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

6.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines.

Authors:  T M Bryan; A Englezou; L Dalla-Pozza; M A Dunham; R R Reddel
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

7.  Supression of telomerase activity in HL60 cells after treatment with differentiating agents.

Authors:  D Xu; A Gruber; C Peterson; P Pisa
Journal:  Leukemia       Date:  1996-08       Impact factor: 11.528

8.  Reconstitution of human telomerase activity in vitro.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Curr Biol       Date:  1998-01-29       Impact factor: 10.834

9.  Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.

Authors:  O E Bechter; W Eisterer; G Pall; W Hilbe; T Kühr; J Thaler
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

10.  Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia.

Authors:  D Xu; A Gruber; C Peterson; P Pisa
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

View more
  13 in total

1.  Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Julieta Panero; Jorge Arbelbide; Dorotea Beatriz Fantl; Hernán García Rivello; Dana Kohan; Irma Slavutsky
Journal:  Mol Med       Date:  2010-07-14       Impact factor: 6.354

2.  Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.

Authors:  Aaron P Rapoport; Nicole A Aqui; Edward A Stadtmauer; Dan T Vogl; Hong-Bin Fang; Ling Cai; Stephen Janofsky; Anne Chew; Jan Storek; Gorgun Akpek; Ashraf Badros; Saul Yanovich; Ming T Tan; Elizabeth Veloso; Marcela F Pasetti; Alan Cross; Sunita Philip; Heather Murphy; Rita Bhagat; Zhaohui Zheng; Todd Milliron; Julio Cotte; Andrea Cannon; Bruce L Levine; Robert H Vonderheide; Carl H June
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

Review 3.  The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Authors:  K H Shain; W S Dalton; J Tao
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

4.  Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity.

Authors:  Jinbo Gao; Jinghui Zhang; Yaoping Long; Yuan Tian; Xiaoming Lu
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

5.  Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

Authors:  Lucía López-Corral; Luis Antonio Corchete; María Eugenia Sarasquete; María Victoria Mateos; Ramón García-Sanz; Encarna Fermiñán; Juan-José Lahuerta; Joan Bladé; Albert Oriol; Ana Isabel Teruel; María Luz Martino; José Hernández; Jesús María Hernández-Rivas; Francisco Javier Burguillo; Jesús F San Miguel; Norma C Gutiérrez
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

6.  Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.

Authors:  Stefan Gattenlöhner; Thorsten Stühmer; Ellen Leich; Matthias Reinhard; Benjamin Etschmann; Hans-Ulrich Völker; Andreas Rosenwald; Edgar Serfling; Ralf Christian Bargou; Georg Ertl; Hermann Einsele; Hans-Konrad Müller-Hermelink
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

7.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

Review 8.  Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.

Authors:  Ivetta Danylesko; Katia Beider; Avichai Shimoni; Arnon Nagler
Journal:  Clin Dev Immunol       Date:  2012-05-10

9.  Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.

Authors:  C Weiss; O Uziel; O Wolach; J Nordenberg; E Beery; S Bulvick; G Kanfer; O Cohen; R Ram; M Bakhanashvili; H Magen-Nativ; N Shilo; M Lahav
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

10.  RDX induces aberrant expression of microRNAs in mouse brain and liver.

Authors:  Baohong Zhang; Xiaoping Pan
Journal:  Environ Health Perspect       Date:  2008-09-19       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.